Martin Samuel Bates — SEC Form 4 filings
SEC reporting owner CIK 1709024. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-03 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 52,172 shares, $1,800,089 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 35,000 shares @ $34.05 ($1,191,774) in Celldex Therapeutics, Inc., filed 2024-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | SVP AND CFO | 6 | — | 2 legs · 52,172 sh · $1,800,089 | 11 |
Form 4 filings — Martin Samuel Bates
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 93,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Celldex Therapeutics, Inc. (CLDX) | Option exercise (M): 4,817 @ $10.38 · Option exercise (M): 4,817 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Celldex Therapeutics, Inc. (CLDX) | Option exercise (M): 3,201 @ $9.02 · Option exercise (M): 16,968 @ $10.38 · Sale (S): 17,172 @ $35.42 · Option exercise (M): 3,201 (derivative) @ $0 · Option exercise (M): 16,968 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Celldex Therapeutics, Inc. (CLDX) | Option exercise (M): 25,000 @ $10.38 · Sale (S): 35,000 @ $34.05 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709024 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →